Cerba HealthCare S.A.S.

Cerba HealthCare S.A.S. is a clinical pathology laboratory that offers a range of routine and specialized laboratory testing services. The company operates a network of medical laboratories that serve a diverse clientele, including private patients, physicians, hospitals, retirement and nursing homes, as well as pharmaceutical and biotech companies. Cerba HealthCare focuses on both standard laboratory tests and more complex specialty testing, enabling clients to interpret and analyze test results effectively. This comprehensive approach aids in the monitoring of patient health and provides significant insights based on clinical context, enhancing the decision-making process for healthcare providers.

Rudi Mariën

Vice President

5 past transactions

Viroclinics Biosciences

Acquisition in 2021
Viroclinics Biosciences is a prominent contract research and clinical laboratory service provider specializing in virology. The company focuses on diagnostic and preclinical studies, as well as drug development aimed at preventing and treating viral infections, particularly respiratory viruses like influenza. Viroclinics offers an extensive range of virology services that support both new drug development programs and post-marketing surveillance of existing drugs and vaccines. Their capabilities include traditional virology assays and advanced deep sequencing protocols applicable to a wide variety of viruses. Operating BSL2 and BSL3 laboratories, Viroclinics conducts analyses in compliance with international ISO 15189 accreditation standards. The company collaborates closely with the Erasmus MC Viroscience lab, enhancing its expertise in developing antivirals and vaccines while serving the biopharmaceutical community with tailored models for preclinical drug testing and expert guidance.

Labexa

Acquisition in 2021
Labexa is a medical biology group specialized in health diagnostic services.

lifebrain

Acquisition in 2021
Lifebrain is a rapidly expanding platform that consolidates various participants in the diagnostic laboratory market. Established in 2013 and headquartered in Vienna, Austria, the company specializes in providing routine and specialty laboratory testing services. It was founded and is managed by the original creators of FutureLAB, a laboratory group that has since merged with Synlab, a prominent entity in Europe’s diagnostic sector. Lifebrain aims to enhance the efficiency and quality of laboratory services within the healthcare landscape.

Accolab

Acquisition in 2018
Accolab is a medical diagnostics laboratory operating in France and Spain, providing essential services to patients and healthcare professionals. Established in 1998 and headquartered in Lesparre-Médoc, France, the company focuses on integrating a network of medical biology laboratories, bringing together biologists, nurses, quality experts, secretaries, and technicians to enhance patient care. As of December 2019, Accolab functions as a subsidiary of Labexa, further strengthening its capabilities in the diagnostics sector.

Novescia

Acquisition in 2015
Novescia SAS is a French company that specializes in medical biology analysis through its network of private diagnostic laboratories. It operates over 100 laboratories across France, organized around six technical centers, and aims to streamline services by transforming laboratories into accessible sampling points for patients. Novescia emphasizes the importance of collaboration among practicing biologists and is committed to efficient service delivery. The company is distinguished by its adherence to shared professional practices and ethical business principles, fostering a corporate culture focused on continuous improvement. Its specialized laboratory services cater to both the healthcare sector and research industries.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.